NOVAVAX CEO to Present at 2008 UBS Global Life Sciences Conference

Saturday, September 20, 2008 General News J E 4
ROCKVILLE, Md., Sept. 19 Novavax, Inc.(Nasdaq: NVAX) a clinical-stage vaccine company, announced today thatDr. Rahul Singhvi, President and Chief Executive Officer, will be presentingat the 2008 UBS Global Life Sciences Conference in New York, NY. Theconference is being held September 22-25, 2008 at The Grand Hyatt Hotel.Dr. Singhvi will be presenting Thursday, September 25, 2008 at 10:30 am.Eastern Time. Dr. Singhvi will provide an overview of the company's strategy,research and development progress.

A link to the live presentation can be accessed via the Company website An archive of the presentation will be available one hourafter the event on the Novavax website for 90 days.


Novavax, Inc. is a clinical stage biotechnology company, creating novelvaccines to address a broad range of infectious diseases worldwide usingadvanced proprietary virus-like particle (VLP) technology. The Companyproduces these VLP based, potent, recombinant vaccines utilizing new andefficient manufacturing approaches. Additional information about Novavax isavailable at and in the Company's various filings with theSecurities and Exchange Commission.

SOURCE Novavax, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
MHA Announces Release of RxPertise(TM) Database Co...
Amil Participacoes Acquires Casa de Saude Santa Lu...